Gray Lady Bites Dog
The New York Times wants you to think that being licked by your dog will give you a disease. It probably won’t.
Federal Agencies’ Rampant Incompetence Fuels Zika Outbreak
Promising ways to reduce the population of mosquitoes that carry the Zika virus are available, but federal bureaucrats are dragging their heels.
Congress Must Do More to Combat Unaccountable Bureaucrats’ Funding of Junk Science
Dubious, agenda-driven studies on hot-button issues such as BPAs and bioengineering are draining funds from vital public-health research.
The Phony Case Against Glyphosate
The EPA’s ban on glyphosate herbicide was driven entirely by political pressure from green activist groups.
Regulators’ Infectious Zika Incompetence
Genetically modified mosquitoes could dramatically reduce cases of Zika virus, but the federal bureaucracy can’t get its act together.
What’s in a Name? Plenty, if It’s a ‘GMO.’
The word ‘GMO’ is meaningless; today’s genetic-modification techniques are less drastic than ones that have been in use for centuries.
Obama’s Dysfunctional ‘Cancer Moonshot’
President Obama’s “Cancer Moonshot” is ambitious, but it would be better if government would simply get out of medical researchers’ way.
Gene Therapy for Cancer: Overregulation Will Delay Its Benefit to Patients
Overregulation will delay gene therapy for cancer patients.
Will Regulators Continue to Get Away with Murder?
The poorest & most vulnerable disproportionately bear the costs of excess regulation, but they enjoy relatively few benefits.
Regulate Precision Medicine Less and We Can Afford to Fund It Less
The precision-medicine initiative announced by President Obama would benefit more from a sensible reduction of regulation than from throwing federal money at it